Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer.
In a patient population, coordinated use of digital rectal examination and prostate-specific antigen can alert the physician as to the possible existence of prostate cancer. If both are used as first-line studies, abnormality of either can then direct the need for further study by transrectal ultrasonography and, in selected instances, prostatic biopsy. Such sequential use of these tests in a programmed manner results in an increased level of cancer detection as compared with use of the digital rectal examination alone.
Cooner
W H
WH
Section of Urology, Emory Clinic, Atlanta, GA 30322.
D006801:Humans; D008297:Male; D010173:Palpation; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000000981:diagnostic imaging; D012007:Rectum; D014463:Ultrasonography
D017430:Prostate-Specific Antigen